Profile data is unavailable for this security.
About the company
CureVac AG is a clinical-stage biopharmaceutical company, The Company strives to create transformative medicines to protect and improve people’s lives. Fueled by proprietary RNA technology platform combined with two decades of science and manufacturing, The Company is dedicated to creating novel treatments that enable the body to make its own prophylactic and therapeutic drugs.
- Revenue in USD (TTM)73.31m
- Net income in USD-309.95m
- Incorporated2020
- Employees999.00
- LocationCureVac NVFriedrich-Miescher-Str. 15TUEBINGEN 72076GermanyDEU
- Phone+49 707198830
- Fax+49 707 198831101
- Websitehttps://www.curevac.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tourmaline Bio Inc | 0.00 | -35.69m | 641.03m | 44.00 | -- | 1.90 | -- | -- | -2.54 | -2.54 | 0.00 | 13.19 | 0.00 | -- | -- | 0.00 | -14.16 | -- | -14.64 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 42.99 | -- | -- | -- |
| Annexon Inc | 0.00 | -115.16m | 647.66m | 71.00 | -- | 1.79 | -- | -- | -1.22 | -1.22 | 0.00 | 3.42 | 0.00 | -- | -- | 0.00 | -36.04 | -44.06 | -38.13 | -46.93 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 5.43 | -- | 62.56 | -- |
| Humacyte Inc | 0.00 | -139.66m | 651.06m | 183.00 | -- | -- | -- | -- | -1.26 | -1.26 | 0.00 | -0.237 | 0.00 | -- | -- | 0.00 | -91.17 | -- | -100.75 | -- | -- | -- | -- | -- | -- | -40.08 | -- | -- | -100.00 | -- | -825.83 | -- | -- | -- |
| Exscientia PLC (ADR) | 28.01m | -172.66m | 664.37m | 483.00 | -- | 1.66 | -- | 23.72 | -1.36 | -1.36 | 0.2204 | 3.11 | 0.042 | -- | 26.88 | 57,984.14 | -25.87 | -- | -29.52 | -- | -32.45 | -- | -616.50 | -- | -- | -- | 0.0674 | -- | -26.24 | -- | -22.94 | -- | -- | -- |
| SS Innovations International Inc | 14.41m | -23.68m | 665.88m | 239.00 | -- | 39.21 | -- | 46.21 | -0.1396 | -0.1396 | 0.0847 | 0.0995 | 0.6003 | 2.28 | 5.08 | 60,293.01 | -98.66 | -161.38 | -216.15 | -449.76 | 28.42 | -79.79 | -164.35 | -495.77 | 0.9128 | -45.39 | 0.4172 | -- | -- | -- | -846.31 | -- | 159.31 | -- |
| Stoke Therapeutics Inc | 15.16m | -103.57m | 671.79m | 110.00 | -- | 2.75 | -- | 44.32 | -2.18 | -2.18 | 0.317 | 4.64 | 0.0537 | -- | 68.74 | 137,790.90 | -36.68 | -31.62 | -41.57 | -33.92 | -- | -- | -683.31 | -1,775.50 | -- | -- | 0.00 | -- | -29.22 | -- | -3.59 | -- | 11.56 | -- |
| Savara Inc | 0.00 | -75.29m | 683.09m | 37.00 | -- | 5.64 | -- | -- | -0.4317 | -0.4317 | 0.00 | 0.7361 | 0.00 | -- | -- | 0.00 | -58.02 | -36.86 | -62.14 | -39.54 | -- | -- | -- | -102,587.50 | -- | -- | 0.2066 | -- | -- | -- | -43.38 | -- | 15.91 | -- |
| CureVac BV | 73.31m | -309.95m | 686.40m | 999.00 | -- | 1.64 | -- | 9.36 | -1.38 | -1.38 | 0.3272 | 1.87 | 0.0905 | 14.15 | 4.30 | 73,387.72 | -38.24 | -27.93 | -46.79 | -35.70 | -143.38 | -91.31 | -422.77 | -395.90 | 2.28 | -- | 0.0939 | -- | -20.26 | 33.10 | -4.47 | -- | 30.25 | -- |
| Scholar Rock Holding Corp | 0.00 | -203.85m | 689.08m | 150.00 | -- | 5.15 | -- | -- | -2.22 | -2.22 | 0.00 | 1.67 | 0.00 | -- | -- | 0.00 | -79.66 | -38.14 | -89.70 | -44.31 | -- | -- | -- | -647.95 | -- | -- | 0.2726 | -- | -100.00 | -- | -23.26 | -- | -45.61 | -- |
| ORIC Pharmaceuticals Inc | 0.00 | -110.78m | 705.42m | 107.00 | -- | 2.24 | -- | -- | -1.76 | -1.76 | 0.00 | 4.47 | 0.00 | -- | -- | 0.00 | -35.69 | -33.92 | -37.77 | -35.77 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.99 | -- | 10.09 | -- |
| Olema Pharmaceuticals Inc | 0.00 | -109.63m | 710.10m | 80.00 | -- | 3.13 | -- | -- | -2.06 | -2.06 | 0.00 | 3.97 | 0.00 | -- | -- | 0.00 | -50.73 | -30.06 | -56.10 | -31.40 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 7.76 | -- | -- | -- |
| AbCellera Biologics Inc | 33.06m | -153.30m | 718.98m | 586.00 | -- | 0.6472 | -- | 21.75 | -0.5254 | -0.5254 | 0.1133 | 3.77 | 0.0224 | -- | 0.808 | 56,407.85 | -10.39 | 6.08 | -11.11 | 6.67 | -- | -- | -463.77 | 24.69 | -- | -- | 0.00 | 0.00 | -92.17 | 33.91 | -192.35 | -- | 70.96 | -- |
| Zenas Biopharma Inc | 50.00m | -54.76m | 732.98m | 114.00 | -- | -- | -- | 14.66 | -1.38 | -1.38 | 1.26 | 4.04 | -- | -- | -- | 595,238.10 | -- | -- | -- | -- | -- | -- | -109.51 | -- | -- | -- | 0.00 | -- | -- | -- | 68.88 | -- | -- | -- |
| MBX Biosciences Inc | 0.00 | -47.20m | 737.73m | 36.00 | -- | -- | -- | -- | -1.48 | -1.48 | 0.00 | 1.71 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -24.60 | -- | -- | -- |
| Arbutus Biopharma Corp | 10.06m | -77.09m | 738.14m | 73.00 | -- | 6.03 | -- | 73.37 | -0.4416 | -0.4416 | 0.0575 | 0.6488 | 0.0597 | -- | 4.59 | 137,821.90 | -45.77 | -52.62 | -53.21 | -58.11 | -- | -- | -766.20 | -537.81 | -- | -- | 0.00 | -- | -53.51 | 25.00 | -4.89 | -- | -2.40 | -- |
Data as of Sep 26 2024. Currency figures normalised to CureVac NV's reporting currency: US Dollar USD
4.64%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Millennium Management LLCas of 30 Jun 2024 | 2.87m | 1.28% |
| Point72 Asset Management LPas of 30 Jun 2024 | 2.42m | 1.08% |
| Bill & Melinda Gates Foundation Trust (Investment Management)as of 30 Jun 2024 | 1.60m | 0.71% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 821.50k | 0.37% |
| BlackRock Advisors LLCas of 30 Jun 2024 | 762.03k | 0.34% |
| Camber Capital Management LPas of 30 Jun 2024 | 550.00k | 0.25% |
| Aperio Group LLCas of 30 Jun 2024 | 512.85k | 0.23% |
| Goldman Sachs & Co. LLC (Private Banking)as of 30 Jun 2024 | 307.07k | 0.14% |
| DZ PRIVATBANK SAas of 30 Jun 2024 | 279.27k | 0.13% |
| Morgan Stanley & Co. LLCas of 30 Jun 2024 | 272.79k | 0.12% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
